UPDATE: JPMorgan Downgrades Actus Medical (AFIB) to Neutral

Go back to UPDATE: JPMorgan Downgrades Actus Medical (AFIB) to Neutral

William Blair Downgrades Actus Medical (AFIB) to Market Perform

March 19, 2021 2:08 AM EDT

William Blair analyst Ryan Daniels downgraded Actus Medical (NASDAQ: AFIB) from Outperform to Market Perform.


For an analyst ratings summary and ratings history on Actus Medical click here. For more ratings news on Actus Medical click here.


Shares of Actus Medical closed at $16.83 yesterday.

... More

Actus Medical (AFIB) PT Lowered to $26 at BTIG, Following Earnings

March 18, 2021 2:22 PM EDT

BTIG analyst Marie Thibault lowered the price target on Actus Medical (NASDAQ: AFIB) to $26.00 (from $40.00) while maintaining a Buy rating.

... More